Market Tracker

07/31 6:01pm ET

Myriad Genetics Inc (NASDAQ:MYGN)

34.12
Delayed Data
As of Jul 31
 +0.485 / +1.44%
Today’s Change
31.34
Today|||52-Week Range
39.95
+0.18%
Year-to-Date

Today’s Trading

Previous close33.64
Today’s open33.82
Day’s range33.46 - 34.19
Volume438,354
Average volume (3 months)701,853
Market cap$2.4B
Dividend yield--
Data as of 3:59pm ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)+27.12%
Earnings growth (this year)-40.04%
Earnings growth (next 5 years)+12.97%
Revenue growth (last year)+26.92%
P/E ratio27.2
Price/Sales3.91
Price/Book3.49

Competitors

 Today’s
change
Today’s
% change
TSROTESARO Inc+0.57+0.99%
CMRXChimerix Inc+0.73+1.38%
--COSMO Pharmaceutical...+1.20+0.75%
GLPGGalapagos NV+3.60+6.31%
Data as of 3:59pm ET, 07/31/2015

Financials

Next reporting dateAugust 12, 2015
EPS forecast (this quarter)$0.41
Annual revenue (last year)$778.2M
Annual profit (last year)$176.2M
Net profit margin22.64%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Mark C. Capone
Executive Vice President-
International Operations
Gary A. King
Corporate headquarters
Salt Lake City, Utah

Forecasts